Pulse Oximeter Reading 98% in a House-Fire Victim with a Measured SaO2 of 72%
A 62-year-old man is brought to the emergency department after being carried from a house fire. He is confused, has soot around the nares, a respiratory rate of 26, and is on 2 L/min nasal cannula. The bedside monitor shows SpO2 98% with a good plethysmographic waveform. Arterial blood gas: pH 7.32, PaCO2 33 mmHg, PaO2 96 mmHg, and co-oximetry reports fractional SaO2 72%, carboxyhemoglobin 31%, hemoglobin 14.2 g/dL. The ED physician pages biomedical engineering because "the monitor is reading wrong and needs calibrating." The unit is a two-wavelength fingertip pulse oximeter with a manufacturer accuracy claim of ±2% for 70–100% SpO2, validated in healthy adult volunteers under controlled conditions.
1. Explain to the physician why the oximeter reads 98% while true arterial saturation is 72%, including the oxygen-content arithmetic that shows why the patient is symptomatic.
Read the worked answer
The monitor is not miscalibrated - it is being asked a question it cannot answer.
Two-wavelength pulse oximetry compares light absorption at roughly 660 nm (red) and 940 nm (infrared) and assumes the only hemoglobin species present are oxyhemoglobin and deoxyhemoglobin. Carboxyhemoglobin absorbs at 660 nm very similarly to oxyhemoglobin. The device therefore classifies carboxyhemoglobin-bound hemoglobin as oxygenated and reports a functional saturation - the fraction of the hemoglobin it can distinguish - which is why 98% appears on the screen while the co-oximeter, which uses multiple wavelengths and reports fractional saturation, finds 72%.
Why he is sick despite a normal PaO2. Dissolved oxygen is adequate (PaO2 96 mmHg), but oxygen content depends on how much hemoglobin is actually carrying O2:
CaO2 = 1.34 × Hb × SaO2 + 0.003 × PaO2 = 1.34 × 14.2 × 0.72 + 0.003 × 96 ≈ 13.7 + 0.29 ≈ 14.0 mL/dL
A normal value is roughly 20 mL/dL, so oxygen delivery is down about 30%. Combined with a left-shifted dissociation curve from carbon monoxide, tissue delivery is worse than the number alone suggests - hence confusion and lactic acidosis (pH 7.32).
Key point for the physician: the SpO2 will keep reading falsely normal until carboxyhemoglobin falls, so it must not be used to titrate oxygen or judge severity. Treat with high-flow oxygen and evaluate for hyperbaric therapy based on COHb level, symptoms, and clinical status. Do not "calibrate" the device and do not swap it for an identical model.
2. What device features, settings, and measurement conditions matter here, and what would you advise the clinical team to use instead?
Read the worked answer
Where the current measurement fails:
- Wavelength count. Two-wavelength devices cannot separate carboxyhemoglobin or methemoglobin from oxyhemoglobin. Multi-wavelength co-oximetry can, and should drive management.
- Accuracy claim context. The ±2% figure for 70–100% was derived from healthy volunteers with normal hemoglobin species, adequate perfusion, and minimal motion. None of those conditions hold in a fire victim with possible hypoperfusion.
- Perfusion and signal quality. A good plethysmographic waveform confirms a pulsatile signal, not a valid saturation; it can look excellent in CO poisoning.
- Known interferents to consider and exclude: methemoglobinemia (classically produces a saturation plateau near 85% that does not respond to oxygen), severe anemia, motion, ambient light, nail polish, and poor peripheral perfusion.
What to use instead: invasive or noninvasive multi-wavelength co-oximetry to follow fractional SaO2 and COHb, correlated with the blood gas. The trend to watch is the COHb level and the patient's clinical status, not the pulse oximeter.
What to tell the team, in practical terms:
- SpO2 will read falsely reassuring until COHb clears; do not use it as a target.
- Continue 100% oxygen regardless of the SpO2 value.
- Expect the SpO2 to fall as COHb falls, because true saturation is being revealed, not worsened.
- Document the limitation in the chart so the next clinician does not repeat the error.
3. What does this event imply for device selection and user training across the organization? Give concrete procurement and policy actions.
Read the worked answer
The lesson: a monitor that is functioning exactly as cleared and labeled can still produce a dangerously misleading number when used outside its validated conditions. The failure here is a system failure - selection and training - not a biomed calibration failure.
Procurement actions:
- For ED, EMS, and hyperbaric/occupational settings, require multi-wavelength co-oximetry capable of reporting carboxyhemoglobin and methemoglobin, or ensure rapid access to blood co-oximetry.
- Require vendors to state the validation population and the range of conditions covered, not just a single ±2% headline figure. Ask what the device does in dyshemoglobinemia, low perfusion, and motion.
- Add device-specific limitations to the equipment file and to the formulary/evaluation record so the next purchase decision inherits the knowledge.
Policy and training actions:
- Write an explicit clinical policy: SpO2 is not a valid measure of oxygenation when abnormal hemoglobin species are suspected, and must not be used to rule out CO poisoning.
- Add a suspicion trigger to triage: fire, closed-space exposure, unexplained confusion, or an SpO2 that "does not fit" the patient.
- Train nursing and respiratory therapy that a normal SpO2 with a sick patient means question the measurement, not the patient.
- Review whether the displayed SpO2 is labeled with its functional-saturation meaning; if not, add a placard.
Judgement point: the temptation is to close this as a monitor problem and swap the device. Doing so leaves the real hazard - an organization-wide belief that SpO2 equals saturation - fully intact.